Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia
Hematology and Cell Therapy · 1996-12 · 38 (6) · 495-504
DOI: 10.1007/s00282-996-0495-9 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematology and Cell Therapy, 1996-12. Verfasst von F Lacombe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Hématologie, CHR Bordeaux, Hôpital Haut-Lévèque, France. Die Arbeit wurde bisher 28-mal zitiert (Crossref).
Abstract (Originalsprache)
The response to therapy of leukemic cells is largely determined by their capacity of proliferation and apoptosis in presence of the administered drugs. We describe here the main markers used in flow cytometry (FCM) and involved in the assessment of cell cycle parameters: single labeling by Propidium Iodide (PI) and double labeling anti-Bromodeoxyuridine (BrdUrd)/PI which, both in vitro and in vivo, gives cell percentages in the different cell cycle phases. The markers of cell cycle progression can be divided into proliferation markers such as PCNA (proliferating cell nuclear antigen) or Ki-67 and cell cycle progression markers. The latter, which are the core of the cell cycle machinery, are molecules recently characterized (Cyclins, CDKs (cell dependent kinases), CDIs (cyclin-dependent kinase inhibitors)) and their cell expression can be analyzed using FCM. FCM is also one of the best means to detect and quantitate apoptotic cells. Several techniques are described: Nuclear labeling using Hoechst 33342: mitochondrial labeling using DiOC6(3): detection of DNA fragmentation using 1) labeling of fixed and permeabilized cells with a DNA marker or 2) labeling of the free 3' DNA ends using incorporation of labeled deoxynucleotides; detection in apoptotic cells (Bcl-2, Fas, phospholipids...). At last, we analyzed flow cytometry methods to study the cell resistance to Ara-C and anthracyclins. In combination with cell kinetic studies and detection of apoptotic cells, they should increase the efficiency of the acute leukemia treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Hématologie, CHR Bordeaux, Hôpital Haut-Lévèque, France.
Zitieren
APA
Lacombe, F., & Belloc, F. (1996). Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia. Hematology and Cell Therapy, 38(6), 495-504. https://doi.org/10.1007/s00282-996-0495-9
Vancouver
Lacombe F, Belloc F. Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia. Hematology and Cell Therapy. 1996;38(6):495-504. doi:10.1007/s00282-996-0495-9
BibTeX
@article{Lacombe1996,
author = {Lacombe, F and Belloc, F},
title = {Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia},
journal = {Hematology and Cell Therapy},
year = {1996},
volume = {38},
number = {6},
pages = {495--504},
doi = {10.1007/s00282-996-0495-9}
}
EUVIMED